Skip to main content
UniHealth

Doctor search

Andrei H Iagaru, MD

Nuclear Medicine · Stanford

NPI 1750404752

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
1
1 carrier
Offices
6

Offices

6 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

1 plan · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Iagaru’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A92375 · Current

Licensed to practise in California · since 2005 · expires 2027-08-31 · University of Medicine and Pharmacy 'Carol Davila'.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$49,562

Medicare paid this office $49,562 for 898 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Nuclear medicine study from skull base to mid-thigh with ct scan150$15,103$99
Nuclear medicine study from skull base to mid-thigh with ct scan55$5,350$96
Nuclear medicine study whole body with ct scan45$4,864$99
Nuclear medicine studies of heart muscle at rest and with stress and spect65$4,116$63
Dxa bone density measurement of hip, pelvis, spine238$2,512$11
See all 14 services
Every Original Medicare service billed
Nuclear medicine study from skull base to mid-thigh with ct scan150$15,103$99
Nuclear medicine study from skull base to mid-thigh with ct scan55$5,350$96
Nuclear medicine study whole body with ct scan45$4,864$99
Nuclear medicine studies of heart muscle at rest and with stress and spect65$4,116$63
Dxa bone density measurement of hip, pelvis, spine238$2,512$11
Nuclear medicine study whole body with ct scan24$2,432$101
Dxa bone density measurement of hip, pelvis, spine146$1,532$10
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging21$1,185$56
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging14$624$45
Nuclear medicine study of stomach to assess emptying19$624$33
Nuclear medicine study of lymphatic system12$586$49
Nuclear medicine study of bone and/or joint whole body14$483$34
Nuclear medicine study of stomach to assess emptying11$357$32
Piflufolastat f-18, diagnostic, 1 millicurie14$0$0

Who their Medicare patients are

898 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 12% · Women 66% · Also on Medicaid 21% · Health risk score 1.85. At or below the middle of the specialty; the typical nuclear medicine clinician is at 1.94.

Conditions among them: High blood pressure 68% · Cancer 37% · Diabetes 28% · Coronary heart disease 28% · Chronic kidney disease 28% · Depression 22% · Atrial fibrillation 20% · Heart failure 17% · COPD 13% · Stroke 10% · Dementia 9%.

The office billed $1,648,659, Medicare allowed $62,349 and paid $49,562; for 967 services of 43 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024898967741.85$1,648,659$49,562
20231,1191,271741.77$1,447,507$67,805
20221,0741,193751.78$849,565$66,727
2021687747741.68$460,107$37,899
2020859948731.89$562,368$56,612
20191,0761,143731.87$456,829$69,138
20181,9612,182731.84$712,748$112,478
20171,6081,770721.74$598,152$99,725
20161,0711,200722.01$457,222$76,944
20151,0381,173721.85$415,096$71,125
20149721,104711.82$370,531$63,247
20139671,104711.75$361,557$57,691

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 13 services

Original Medicare services billed in 2023
Nuclear medicine study from skull base to mid-thigh with ct scan183$19,532$103
Nuclear medicine study from skull base to mid-thigh with ct scan76$8,094$105
Nuclear medicine study whole body with ct scan73$7,920$106
Nuclear medicine studies of heart muscle at rest and with stress and spect88$5,998$68
Dxa bone density measurement of hip, pelvis, spine407$4,439$11
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging66$4,207$62
Nuclear medicine study whole body with ct scan32$3,522$104
Radioactive drug therapy through a vein25$2,465$88
Nuclear medicine study of bone and/or joint whole body31$1,187$36
Calculation of radiation therapy dose29$968$31
Nuclear medicine study of lymphatic system16$820$51
Dxa bone density measurement of hip, pelvis, spine62$668$11
Nuclear medicine study of stomach to assess emptying17$583$34

2022: 14 services

Original Medicare services billed in 2022
Nuclear medicine study from skull base to mid-thigh with ct scan230$23,307$97
Nuclear medicine study from skull base to mid-thigh with ct scan84$8,752$101
Nuclear medicine study whole body with ct scan76$7,806$101
Nuclear medicine studies of heart muscle at rest and with stress and spect98$6,018$61
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging63$3,841$59
Dxa bone density measurement of hip, pelvis, spine310$3,412$11
Nuclear medicine study whole body with ct scan31$3,153$102
Nuclear medicine study of bone and/or joint whole body28$1,024$35
Dxa bone density measurement of hip, pelvis, spine69$748$11
Nuclear medicine study of stomach to assess emptying24$727$30
Nuclear medicine study of lung ventilation and circulation13$609$47
Nuclear medicine study of lymphatic system11$573$52
Nuclear medicine study, 1 area15$426$28
Calculation of radiation therapy dose13$390$30

2021: 8 services

Original Medicare services billed in 2021
Nuclear medicine study from skull base to mid-thigh with ct scan144$14,022$96
Nuclear medicine studies of heart muscle at rest and with stress and spect58$4,043$70
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging53$3,415$63
Nuclear medicine study whole body with ct scan34$3,121$89
Dxa bone density measurement of hip, pelvis, spine234$2,621$11
Nuclear medicine study from skull base to mid-thigh with ct scan20$2,164$108
Nuclear medicine study of bone and/or joint whole body32$1,110$34
Dxa bone density measurement of hip, pelvis, spine44$486$11

2020: 12 services

Original Medicare services billed in 2020
Nuclear medicine study from skull base to mid-thigh with ct scan157$17,897$108
Nuclear medicine study whole body with ct scan65$7,827$112
Nuclear medicine study from skull base to mid-thigh with ct scan65$7,051$107
Nuclear medicine studies of heart muscle at rest and with stress and spect80$5,519$69
Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging57$3,741$66
Dxa bone density measurement of hip, pelvis, spine250$2,883$12
Nuclear medicine study whole body with ct scan17$2,028$113
Nuclear medicine study of bone and/or joint whole body36$1,443$38
Nuclear medicine study of lymphatic system20$1,033$52
Dxa bone density measurement of hip, pelvis, spine41$468$11
Nuclear medicine study of lung circulation13$410$32
Nuclear medicine study of stomach to assess emptying13$402$31

2019: 11 services

Original Medicare services billed in 2019
Nuclear medicine study from skull base to mid-thigh with ct scan219$24,637$106
Nuclear medicine study from skull base to mid-thigh with ct scan100$11,179$107
Nuclear medicine study whole body with ct scan79$9,124$109
Nuclear medicine studies of heart muscle at rest and with stress and spect109$7,621$69
Dxa bone density measurement of hip, pelvis, spine297$3,338$11
Nuclear medicine study whole body with ct scan21$2,310$110
Nuclear medicine study of bone and/or joint whole body48$1,806$36
Nuclear medicine study of stomach to assess emptying24$816$34
Nuclear medicine study of lung ventilation and circulation16$769$48
Dxa bone density measurement of hip, pelvis, spine66$738$11
Nuclear medicine study of lymphatic system11$588$53

2018: 24 services

Original Medicare services billed in 2018
Nuclear medicine study from skull base to mid-thigh with ct scan347$38,119$100
Nuclear medicine study from skull base to mid-thigh with ct scan133$13,423$97
Nuclear medicine studies of heart muscle at rest and with stress and spect193$12,955$67
Nuclear medicine study whole body with ct scan93$11,417$104
Dxa bone density measurement of hip, pelvis, spine626$7,237$12
Nuclear medicine study whole body with ct scan43$4,663$97
Nuclear medicine study of bone and/or joint whole body88$2,898$31
Nuclear medicine study of lung ventilation and circulation42$1,943$46
Nuclear medicine study of stomach to assess emptying56$1,780$31
Nuclear medicine study of lymphatic system34$1,686$50
Dxa bone density measurement of hip, pelvis, spine128$1,469$11
Nuclear medicine studies of heart muscle at rest and with stress and spect21$1,373$65
Nuclear medicine study from skull base to mid-thigh17$954$56
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging21$946$43
Nuclear medicine study of heart muscle with metabolic evaluation12$764$64
Nuclear medicine study of bone taken at different times17$763$45
Nuclear medicine study of kidney, blood, flow, and function with drug administration12$687$53
Nuclear medicine study of heart muscle at rest and with stress and spect12$669$56
Nuclear medicine study of lymphatic system13$633$49
Nuclear medicine study of bone and/or joint13$544$42
Nuclear medicine study, whole body14$473$34
Nuclear medicine study of radioactive material distribution at sites of inflammation in whole body14$452$32
Nuclear medicine study of liver and bile duct system with use of drugs11$402$37
Nuclear medicine study of liver13$331$25

2017: 12 services

Original Medicare services billed in 2017
Nuclear medicine study from skull base to mid-thigh with ct scan449$51,236$102
Nuclear medicine study from skull base to mid-thigh with ct scan117$13,491$107
Nuclear medicine study whole body with ct scan105$11,546$104
Dxa bone density measurement of hip, pelvis, spine698$8,077$12
Nuclear medicine study whole body with ct scan29$3,485$109
Nuclear medicine studies of heart muscle at rest and with stress and spect36$2,287$64
Nuclear medicine study of bone and/or joint whole body47$1,618$32
Nuclear medicine study of lymphatic system17$796$47
Nuclear medicine study of heart muscle with metabolic evaluation14$753$54
Nuclear medicine study of stomach to assess emptying22$645$29
Nuclear medicine study of lung ventilation and circulation15$574$38
Dxa bone density measurement of hip, pelvis, spine49$554$11

2016: 9 services

Original Medicare services billed in 2016
Nuclear medicine study from skull base to mid-thigh with ct scan457$50,578$103
Nuclear medicine study whole body with ct scan63$7,074$103
Nuclear medicine studies of heart muscle at rest and with stress and spect53$3,768$71
Dxa bone density measurement of hip, pelvis, spine307$3,543$12
Nuclear medicine study of bone and/or joint whole body54$1,910$34
Nuclear medicine study of lymphatic system28$1,377$49
Nuclear medicine study of stomach to assess emptying32$958$30
Nuclear medicine study of lung ventilation and circulation19$900$47
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging18$841$47

2015: 12 services

Original Medicare services billed in 2015
Nuclear medicine study from skull base to mid-thigh with ct scan392$45,515$105
Nuclear medicine study whole body with ct scan45$5,107$106
Dxa bone density measurement of hip, pelvis, spine315$3,643$12
Nuclear medicine study of bone and/or joint whole body80$2,880$35
Nuclear medicine studies of heart muscle at rest and with stress and spect42$2,786$66
Nuclear medicine study of lymphatic system28$1,445$52
Nuclear medicine study of lung ventilation and circulation23$1,001$44
Nuclear medicine study of stomach to assess emptying22$782$33
Nuclear medicine study of bone and/or joint14$634$45
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging12$548$46
Nuclear medicine study of liver and bile duct system with use of drugs11$441$40
Nuclear medicine study of liver13$395$30

2014: 16 services

Original Medicare services billed in 2014
Nuclear medicine study from skull base to mid-thigh with ct scan360$41,261$105
Nuclear medicine study of bone and/or joint whole body93$3,418$35
Dxa bone density measurement of hip, pelvis, spine283$3,263$12
Nuclear medicine studies of heart muscle at rest and with stress and spect36$2,202$61
Nuclear medicine study of lung ventilation and circulation35$1,650$46
Nuclear medicine study whole body with ct scan15$1,411$94
Nuclear medicine study of lymphatic system25$1,260$50
Nuclear medicine study of stomach to assess emptying30$1,133$35
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging21$971$46
Nuclear medicine study of bone and/or joint14$605$43
Supervision, handling, and loading of radiation source11$527$48
Nuclear medicine study of bone taken at different times11$493$45
Nuclear medicine study of liver and bile duct system with use of drugs11$440$40
Nuclear medicine study of liver13$365$28
Nuclear medicine study of kidney and blood flow15$347$22
Calculation of radiation therapy dose11$315$29

2013: 13 services

Original Medicare services billed in 2013
Nuclear medicine study from skull base to mid-thigh with ct scan346$36,318$95
Dxa bone density measurement of hip, pelvis, spine297$3,252$11
Nuclear medicine study of bone and/or joint whole body87$3,009$33
Nuclear medicine studies of heart muscle at rest and with stress and spect36$2,234$62
Nuclear medicine study whole body with ct scan19$1,763$88
Nuclear medicine study of lung ventilation and circulation32$1,456$45
Nuclear medicine study of stomach to assess emptying29$1,165$33
Nuclear medicine study of lymphatic system21$1,026$49
Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging20$746$36
Supervision, handling, and loading of radiation source12$550$46
Nuclear medicine study of bone and/or joint11$475$40
Nuclear medicine study of liver and bile duct system with use of drugs11$434$39
Calculation of radiation therapy dose12$327$27

Medicaid work

$23,560 in 2024

Medicaid paid $23,560 for 114 billed services this clinician did in 2024, up to 33 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh88$23,248
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL26$312
Medicaid work by year
2024114233$23,560
2023122224$16,639
2022115226$10,249
202127114$144
202070216$7,876
201956125$11,869
2018249330$32,403
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh96$16,517
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL26$122

2022

Largest Medicaid services in 2022
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh67$10,040
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL48$209

2021

Largest Medicaid services in 2021
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL27$144

2020

Largest Medicaid services in 2020
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh44$7,756
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL26$119

2019

Largest Medicaid services in 2019
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh56$11,869

2018

Largest Medicaid services in 2018
Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh159$31,440
DXA BONE DENSITY STUDY 1/> SITES AXIAL SKEL78$609
Gastric emptying imaging study (eg, solid, liquid, or both)12$354

Money from drug and device companies

$44,138 in 2025

Industry payments by year
2025517$25,545$44,138
2024516$1,400$18,222
2023323$9,063$21,905
2022312$7,012$29,079
202136$10,000$10,229
202037$4,575$11,665
2019130None$15,177

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Lantheus Medical ImagingNone$27,136
4 payments
  • Consulting · 2025-11-25 · $7,950
  • Consulting · 2025-11-18 · $3,975
  • Travel · 2025-11-18 · $7,261
  • Consulting · 2025-11-06 · $7,950
Ge HealthcareNone$10,782
6 payments
  • Meals · 2025-08-24 · $96
  • Meals · 2025-08-22 · $100
  • Travel · 2025-08-22 · $9,540
  • Travel · 2025-08-22 · $682
  • Travel · 2025-06-24 · $239
  • Meals · 2025-06-20 · $124
GenzymeNone$3,197
3 payments
  • Consulting · 2025-01-22 · $2,970
  • Travel · 2025-01-22 · $112
  • Meals · 2025-01-22 · $115
Novartis PharmaceuticalsNone$2,810
3 payments
  • Meals · 2025-06-20 · $34
  • Meals · 2025-02-14 · $76
  • Consulting · 2025-02-14 · $2,700
Progenics PharmaceuticalsPylarify$214
1 payment
  • Meals for Pylarify · 2025-09-11 · $214
See all 17 published payments
Every published payment
Lantheus Medical ImagingConsulting · 2025-11-25None$7,950
Lantheus Medical ImagingConsulting · 2025-11-18None$3,975
Lantheus Medical ImagingTravel · 2025-11-18None$7,261
Lantheus Medical ImagingConsulting · 2025-11-06None$7,950
Progenics PharmaceuticalsMeals · 2025-09-11Pylarify$214
Ge HealthcareMeals · 2025-08-24None$96
Ge HealthcareMeals · 2025-08-22None$100
Ge HealthcareTravel · 2025-08-22None$9,540
Ge HealthcareTravel · 2025-08-22None$682
Ge HealthcareTravel · 2025-06-24None$239
Novartis PharmaceuticalsMeals · 2025-06-20None$34
Ge HealthcareMeals · 2025-06-20None$124
Novartis PharmaceuticalsMeals · 2025-02-14None$76
Novartis PharmaceuticalsConsulting · 2025-02-14None$2,700
GenzymeConsulting · 2025-01-22None$2,970
GenzymeTravel · 2025-01-22None$112
GenzymeMeals · 2025-01-22None$115
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $18,222

Payments by company in 2024
Ge HealthcareNone$16,203
10 payments
  • Meals · 2024-10-23 · $58
  • Meals · 2024-10-23 · $58
  • Meals · 2024-10-08 · $64
  • Meals · 2024-09-11 · $82
  • Travel · 2024-06-18 · $14,894
  • Meals · 2024-06-08 · $67
  • Meals · 2024-06-06 · $96
  • Travel · 2024-06-01 · $631
  • Travel · 2024-06-01 · $165
  • Travel · 2024-06-01 · $87
Eli Lilly andNone$1,454
2 payments
  • Consulting · 2024-10-25 · $1,400
  • Meals · 2024-10-21 · $54
Telix PharmaceuticalsIlluccix$308
2 payments
  • Meals for Illuccix · 2024-07-12 · $149
  • Meals for Illuccix · 2024-07-09 · $159
Novartis PharmaceuticalsPluvicto$216
1 payment
  • Meals for Pluvicto · 2024-05-04 · $216
Bayer Healthcare PharmaceuticalsNubeqa$42
1 payment
  • Meals for Nubeqa · 2024-03-09 · $42

2023: $21,905

Payments by company in 2023
Novartis PharmaceuticalsPluvicto$11,049
11 payments
  • Meals for Leqvio · 2023-12-04 · $110
  • Meals for Pluvicto · 2023-09-23 · $59
  • Meals for Pluvicto · 2023-09-21 · $123
  • Consulting · 2023-07-17 · $5,438
  • Meals · 2023-07-17 · $80
  • Travel · 2023-07-17 · $312
  • Travel · 2023-07-17 · $74
  • Travel · 2023-07-17 · $331
  • Travel · 2023-07-16 · $805
  • Consulting for Pluvicto · 2023-02-15 · $3,625
  • Meals for Pluvicto · 2023-02-15 · $92
GE HealthCareNone$10,832
11 payments
  • Meals · 2023-10-09 · $106
  • Travel · 2023-04-21 · $9,855
  • Meals · 2023-04-21 · $27
  • Meals · 2023-04-19 · $38
  • Meals · 2023-03-16 · $42
  • Meals · 2023-03-15 · $29
  • Meals · 2023-02-28 · $126
  • Meals · 2023-02-28 · $147
  • Meals · 2023-02-26 · $126
  • Meals · 2023-02-26 · $169
  • Meals · 2023-02-26 · $169
Progenics PharmaceuticalsPylarify$23
1 payment
  • Meals for Pylarify · 2023-08-17 · $23

2022: $29,079

Payments by company in 2022
GE HealthCareNone$22,067
10 payments
  • Travel · 2022-12-11 · $285
  • Travel · 2022-12-11 · $12,107
  • Travel · 2022-12-11 · $494
  • Meals · 2022-09-19 · $104
  • Meals · 2022-09-16 · $55
  • Travel · 2022-08-02 · $2,967
  • Travel · 2022-08-02 · $2,967
  • Travel · 2022-08-02 · $2,967
  • Meals · 2022-06-14 · $98
  • Meals · 2022-06-09 · $23
Progenics PharmaceuticalsPylarify$4,500
1 payment
  • Paid to speak or teach for Pylarify · 2022-08-19 · $4,500
AmgenNone$2,512
1 payment
  • Consulting · 2022-12-14 · $2,512

2021: $10,229

Payments by company in 2021
Novartis PharmaceuticalsLutathera$7,116
2 payments
  • Meals for Lutathera · 2021-12-09 · $116
  • Paid to speak or teach · 2021-05-01 · $7,000
Progenics PharmaceuticalsPylarify$3,000
1 payment
  • Consulting for Pylarify · 2021-07-23 · $3,000
Ge HealthcareNone$113
3 payments
  • Meals · 2021-08-26 · $26
  • Meals · 2021-08-16 · $48
  • Meals · 2021-08-16 · $39

2020: $11,665

Payments by company in 2020
GE HealthcareNone$7,090
5 payments
  • Meals · 2020-02-26 · $18
  • Travel · 2020-01-30 · $7,016
  • Meals · 2020-01-22 · $19
  • Meals · 2020-01-17 · $21
  • Meals · 2020-01-01 · $17
Progenics PharmaceuticalsNone$2,700
1 payment
  • Paid to speak or teach · 2020-07-24 · $2,700
Advanced Accelerator ApplicationsLutathera$1,875
1 payment
  • Consulting for Lutathera · 2020-07-07 · $1,875

2019: $15,177

Payments by company in 2019
Ge HealthcareNone$15,177
30 payments
  • Meals · 2019-12-13 · $37
  • Meals · 2019-11-26 · $103
  • Meals · 2019-11-22 · $17
  • Meals · 2019-11-14 · $20
  • Meals · 2019-11-01 · $32
  • Meals · 2019-10-31 · $18
  • Meals · 2019-10-31 · $18
  • Meals · 2019-10-24 · $34
  • Meals · 2019-10-18 · $38
  • Meals · 2019-10-17 · $346
  • Travel · 2019-10-17 · $99
  • Meals · 2019-10-11 · $17
  • Meals · 2019-10-03 · $16
  • Meals · 2019-08-14 · $89
  • Meals · 2019-08-14 · $26
  • Meals · 2019-07-26 · $14
  • Meals · 2019-06-27 · $50
  • Meals · 2019-06-25 · $28
  • Travel · 2019-06-05 · $7,723
  • Meals · 2019-05-22 · $24
  • Meals · 2019-05-01 · $30
  • Meals · 2019-04-26 · $21
  • Travel · 2019-04-07 · $6,119
  • Meals · 2019-04-05 · $68
  • Meals · 2019-04-04 · $73
  • Meals · 2019-04-01 · $27
  • Meals · 2019-03-08 · $22
  • Meals · 2019-02-28 · $21
  • Meals · 2019-02-01 · $23
  • Meals · 2019-01-08 · $23

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
GE HEALTHCARE · Pard Projects · 2019Their institution$749,837
GE HEALTHCARE · Mri Technology Development/Evaluation · 2023Their institution$603,180
GE HEALTHCARE · Advanced Research for Digital Petct · 2020Their institution$444,540
Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2023Their institution$363,542
GE HEALTHCARE · Digital Pet/Ct Evaluations · 2019Their institution$326,062
GE HEALTHCARE · Pet/Mri Advanced Research and Development - Neuro · 2022Their institution$307,591
GE Healthcare · Advanced Pet Application Testing · 2021Their institution$301,591
Novartis Pharmaceuticals Corporation · (Ma-Psmar2-1-2) 68ga-Neobomb1 and 68ga-Psma R2 Pet/Mri in the Evaluation of Patients With Biochemical Recurrence of Prostate Cancer · 2024Their institution$249,360
Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2024Their institution$174,294
Progenics Pharmaceuticals, Inc. · Study of 18f Dcfpyl Pet Ct Imaging in Patients With Suspected Recurrence of Prostate Cancer Condor · 2019Their institution$37,684
GE HEALTHCARE · Early Evaluation of Starguide Spect/Ct in Clinical Practice · 2022Their institution$28,463
AstraZeneca Pharmaceuticals LP · A Phase 1 First-in-Human Multicentre Open-Label Dose Escalation Study of 225ac-Fpi-2068 in Adult Patients With Advanced Solid Tumours · 2025Their institution$27,725
Progenics Pharmaceuticals, Inc. · Phase 3 Randomized Trial of Psma Pet Prior To Definitive Radiotherapy for Intermediate- Or High-Risk Prostate Cancer · 2021Their institution$23,000
Progenics Pharmaceuticals, Inc. · Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone (Arrow) · 2020Their institution$18,630
Progenics Pharmaceuticals, Inc. · Impact of Pyl Pet/Ct on Initial and Subsequent Treatment Strategies of Patients With Prostate Cancer (Prospyl) · 2021Their institution$18,400
Advanced Accelerator Applications · Neoray · 2020Their institution$17,984
Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2022Their institution$14,972
GE HEALTHCARE · Early Evaluation of Starguide Spect/Ct in Clinical Practice · 2021Their institution$14,232
Progenics Pharmaceuticals, Inc. · 18f-Dcfpyl Pet/Ct in the Evaluation of Patients With Bcr of Prostate Cancer and Non-Contributory Ct Scans · 2021Their institution$13,800
Progenics Pharmaceuticals, Inc. · Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant · 2022Their institution$11,840
Progenics Pharmaceuticals, Inc. · A Phase II Multi-Institutional Trial To Evaluate Prostate Specific Membrane Antigen (Psma)-Based Pet Imaging of High Risk Prostate Cancer-Moonshot-Mskcc · 2021Their institution$9,200
GE HEALTHCARE · Stanford Pet-Mr · 2021Their institution$6,000
Progenics Pharmaceuticals, Inc. · 18f-Dcfpyl Pet/Ct in Men With Prostate Cancer · 2021Their institution$4,600
Progenics Pharmaceuticals, Inc. · The Utility of Psma-Pet Imaging for Detecting Early Metastatic Prostate Cancer in Men With High Gc Decipher Test Scores:A Sub-Aim of the Vandaam Study (Mcc #18523) · 2021Their institution$4,600
Progenics Pharmaceuticals, Inc. · Study of 18f Dcfpyl Pet Ct Imaging in Patients With Suspected Recurrence of Prostate Cancer Condor · 2020Their institution$2,131
PROGENICS PHARMACEUTICALS, INC. · Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castra · 2023Their institution$1,280
Novartis Pharma AG · Caaa617d12302 · 2025This clinician$1,125
Novartis Pharmaceuticals Corporation · Research Publication/Writing Support · 2025This clinician$509
Novartis Pharmaceuticals Corporation · A Phase I, Open-Label, Multi-Center Study To Evaluate the Safety, Tolerability, Dosimetry and Preliminary Activity of [177lu]Lu-Ff58 in Patients With Selected Advanced Solid Tumors · 2024Their institution$505
Progenics Pharmaceuticals, Inc. · Study of 18f Dcfpyl Pet Ct Imaging in Patients With Suspected Recurrence of Prostate Cancer Condor · 2020This clinician$175
Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2025Their institution$115

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1750404752
Licence
CA A92375California A92375: Current · expires 2027-08-31
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 2085N0904X (2085N0904X); Federal specialty code 207U00000X (207U00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2007-04-06
NPI last updated
2024-04-09
NPI record certified
2024-04-09

This is when the NPI record was last certified, not a medical board exam.